| Jangka wektu | Prediksi rega | kepungkur | Sajarah | Wawasan |
|---|---|---|---|---|
| sesuk | $14.85 ▲ +1.59% | wingi | $14.52 ▼ -0.67% | Tomorrow's Trevi Therapeutics Inc. Common Stock (TRVI) setup is anchored to $14.62 and targets $14.85 (+1.59%). The near-term read is upside; watch $15.06 / $14.18 because daily realized volatility is about 8.00%. |
Tomorrow's Trevi Therapeutics Inc. Common Stock (TRVI) setup is anchored to $14.62 and targets $14.85 (+1.59%). The near-term read is upside; watch $15.06 / $14.18 because daily realized volatility is about 8.00%. | ||||
| Minggu | $15.34 ▲ +4.95% | Minggu kepungkur | $14.32 ▼ -2.08% | The 7-day Trevi Therapeutics Inc. Common Stock model moves from $14.32 to $15.34 (+4.95%). It gives upside momentum context for this stock, so breaks around $15.06 / $14.18 matter more than a single tick. |
The 7-day Trevi Therapeutics Inc. Common Stock model moves from $14.32 to $15.34 (+4.95%). It gives upside momentum context for this stock, so breaks around $15.06 / $14.18 matter more than a single tick. | ||||
| wulan | $16.16 ▲ +10.54% | Wulan kepungkur | $13.97 ▼ -4.43% | The 1-month Trevi Therapeutics Inc. Common Stock target is $16.16 (+10.54%), compared with the live reference near $14.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Trevi Therapeutics Inc. Common Stock target is $16.16 (+10.54%), compared with the live reference near $14.62. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| taun | $17.39 ▲ +18.93% | Taun kepungkur | $13.46 ▼ -7.95% | The 1-year Trevi Therapeutics Inc. Common Stock scenario points to $17.39 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Trevi Therapeutics Inc. Common Stock scenario points to $17.39 (+18.93%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 taun | $20.26 ▲ +38.57% | 5 Taun kepungkur | $12.25 ▼ -16.20% | The 5-year Trevi Therapeutics Inc. Common Stock view is $20.26 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Trevi Therapeutics Inc. Common Stock view is $20.26 (+38.57%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indikator | Nilai | Sinyal |
|---|---|---|
| Price | $14.62 | Mid |
| Daily Change | -5.07% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 68% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $14.62 | Daily Change | -5.07% |
| Market Cap | $1.88B | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.